Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka

In this cross-sectional descriptive study conducted in the Ratnapura district, Sri Lanka, we assessed the affordability of oral pediatric anti-infective medicines (OPAIMs). Using a modified WHO/HAI medicinal price methodology, we examined the availability, median price ratios (MPRs), mean percentage...

Full description

Bibliographic Details
Main Authors: Malith Kumarasinghe, Manuj C. Weerasinghe
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Pharmacoepidemiology
Subjects:
Online Access:https://www.mdpi.com/2813-0618/3/1/11
_version_ 1827305247411798016
author Malith Kumarasinghe
Manuj C. Weerasinghe
author_facet Malith Kumarasinghe
Manuj C. Weerasinghe
author_sort Malith Kumarasinghe
collection DOAJ
description In this cross-sectional descriptive study conducted in the Ratnapura district, Sri Lanka, we assessed the affordability of oral pediatric anti-infective medicines (OPAIMs). Using a modified WHO/HAI medicinal price methodology, we examined the availability, median price ratios (MPRs), mean percentage difference, and affordability of the standard treatment of the originator brand (OB) and lowest-priced generic (LPG) OPAIMs in 30 private and 2 state-owned pharmacies. The study revealed disparities in availability, with only 50% of private pharmacies offering all 11 medicinal drugs in their generic form. The MPRs of OPAIMs for OB and LPG varied, with three drugs exceeding the financially acceptable MPR of 2 (albendazole, amoxicillin, and erythromycin). The standard treatment with LPGs costs between 0.17 and 0.85 and between 0.06 and 0.28 days’ wages for the lowest daily salary of the private sector and unskilled public employees, respectively. We identified erythromycin and albendazole as having less than 50% availability in their generic form in private pharmacies. To address these findings, we recommend frequent pricing revisions based on exchange rates and associated costs, coupled with the establishment of a transparent scientific criterion to subsidize essential medicines deemed “unaffordable.” Failure to implement such measures amidst economic crises may adversely impact financial access to essential medications.
first_indexed 2024-04-24T17:55:01Z
format Article
id doaj.art-5c38c251f25f4b61b9d03c1d77b8a6f8
institution Directory Open Access Journal
issn 2813-0618
language English
last_indexed 2024-04-24T17:55:01Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Pharmacoepidemiology
spelling doaj.art-5c38c251f25f4b61b9d03c1d77b8a6f82024-03-27T13:59:56ZengMDPI AGPharmacoepidemiology2813-06182024-03-013118319710.3390/pharma3010011Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri LankaMalith Kumarasinghe0Manuj C. Weerasinghe1Postgraduate Institute of Medicine, University of Colombo, 160, Prof. Nandadasa Kodagoda Mawatha, Colombo 00700, Sri LankaDepartment of Community Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 00800, Sri LankaIn this cross-sectional descriptive study conducted in the Ratnapura district, Sri Lanka, we assessed the affordability of oral pediatric anti-infective medicines (OPAIMs). Using a modified WHO/HAI medicinal price methodology, we examined the availability, median price ratios (MPRs), mean percentage difference, and affordability of the standard treatment of the originator brand (OB) and lowest-priced generic (LPG) OPAIMs in 30 private and 2 state-owned pharmacies. The study revealed disparities in availability, with only 50% of private pharmacies offering all 11 medicinal drugs in their generic form. The MPRs of OPAIMs for OB and LPG varied, with three drugs exceeding the financially acceptable MPR of 2 (albendazole, amoxicillin, and erythromycin). The standard treatment with LPGs costs between 0.17 and 0.85 and between 0.06 and 0.28 days’ wages for the lowest daily salary of the private sector and unskilled public employees, respectively. We identified erythromycin and albendazole as having less than 50% availability in their generic form in private pharmacies. To address these findings, we recommend frequent pricing revisions based on exchange rates and associated costs, coupled with the establishment of a transparent scientific criterion to subsidize essential medicines deemed “unaffordable.” Failure to implement such measures amidst economic crises may adversely impact financial access to essential medications.https://www.mdpi.com/2813-0618/3/1/11paediatricanti-infectivemedicinesaffordabilitySri Lanka
spellingShingle Malith Kumarasinghe
Manuj C. Weerasinghe
Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka
Pharmacoepidemiology
paediatric
anti-infective
medicines
affordability
Sri Lanka
title Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka
title_full Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka
title_fullStr Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka
title_full_unstemmed Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka
title_short Affordability of Paediatric Oral Anti-Infective Medicines in a Selected District, Sri Lanka
title_sort affordability of paediatric oral anti infective medicines in a selected district sri lanka
topic paediatric
anti-infective
medicines
affordability
Sri Lanka
url https://www.mdpi.com/2813-0618/3/1/11
work_keys_str_mv AT malithkumarasinghe affordabilityofpaediatricoralantiinfectivemedicinesinaselecteddistrictsrilanka
AT manujcweerasinghe affordabilityofpaediatricoralantiinfectivemedicinesinaselecteddistrictsrilanka